Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap 2024-01-08 21:38
YS Biopharma Announces Changes to its Board Committees 2024-01-08 21:00
Novel Technology Transforms Baldness Treatment Using Beard and Body Hair 2024-01-08 21:00
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries 2024-01-08 20:30
The World's First Clinical Base Editing Therapy for Hemoglobinopathy 2024-01-08 19:46
Biosion's Partner OBI Pharma Announces FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992 (TROP2 ADC) 2024-01-08 19:35
So-Young Announces Update on Repurchase and Cancellation of Shares 2024-01-08 19:00
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts 2024-01-08 17:52
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report 2024-01-08 16:00
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa 2024-01-08 15:30
Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease 2024-01-08 13:25
2024 Trend Forecast for Cosmetic Surgery & Medical Aesthetics in Singapore 2024-01-08 09:00
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 2024-01-08 09:00
Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products 2024-01-08 08:00
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis 2024-01-08 07:00
Supplemental New Drug Application for Akeso's Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer 2024-01-05 21:00
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio 2024-01-05 19:44
Grant of Restricted Share Units to Mr. Xing Jin 2024-01-05 19:00
SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease 2024-01-05 16:00
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide 2024-01-05 14:35
1 45 46 47 48 49 902